Renji Hospital Shanghai Jiao Tong University School of Medicine
Renji Hospital Shanghai Jiao Tong University School of Medicine: Centuries of Western Medical Heritage · Precision Medicine with Compassion · Global Health Partnership
I. Hospital Profile
Renji Hospital Shanghai Jiao Tong University School of Medicine (hereinafter referred to as “Renji Hospital”) was founded in 1844 by William Lockhart, a missionary of the London Missionary Society. Originally named “Renji Medical Clinic,” it stands as one of China's earliest Western medicine hospitals and is hailed as the “cradle of Western medical education in China.” As a Grade A tertiary general hospital directly affiliated with Shanghai Jiao Tong University School of Medicine and a National Center for Diagnosis and Treatment of Complex and Critical Diseases designated by the National Health Commission, Renji Hospital upholds “Compassionate Medicine for the World” as its core ethos. With over 180 years of heritage, it has evolved into a premier modern medical center integrating medical care, teaching, research, prevention, health preservation, and rehabilitation. Renji consistently ranks among China's top 20 hospitals in comprehensive strength.
Currently, Renji Hospital operates across four campuses: East Campus (160 Pujian Road, Pudong New Area), West Campus (145 Shandong Middle Road, Huangpu District), South Campus (2000 Jiangyue Road, Minhang District), and North Campus (85 Wujin Road, Hongkou District). With over 4,000 open beds, it handles more than 20 million outpatient and emergency visits annually, covering all disciplines including internal medicine, surgery, obstetrics and gynecology, and pediatrics. The hospital hosts national-level platforms including a State Key Laboratory (Development and Disease), a National Clinical Research Center (Critical Care Medicine), and an Education Ministry Key Laboratory (Allergy Science and Immunology). It has established international influence in gastroenterology, rheumatology, urology, and reproductive medicine.
II. Technical Advantages: Driving Precision Innovation to Tackle Complex Diseases
Guided by the mission to “solve clinical challenges,” Renji Hospital has achieved technological breakthroughs across multiple disciplines, maintaining leading positions in China and advanced international standards in areas including digestive system diseases, autoimmune disorders, prostate cancer, and assisted reproductive technology:
• Gastroenterology: One of China's earliest institutions to perform endoscopic diagnostics and treatments, conducting over 1 million gastrointestinal endoscopies annually. Globally leading in emergency endoscopic hemostasis for esophageal and gastric variceal bleeding, endoscopic submucosal dissection (ESD), and peroral endoscopic myotomy (POEM). Achieves over 95% detection rate for early-stage digestive tract cancers.
• Rheumatology and Immunology: Led the development of national guidelines, including the Chinese Guidelines for the Diagnosis and Treatment of Systemic Lupus Erythematosus and the Chinese Standards for the Diagnosis and Treatment of Rheumatoid Arthritis. Maintains China's benchmark in biologic targeted therapies (e.g., IL-6 inhibitors, JAK inhibitors) and treatment of refractory rheumatic diseases (e.g., ANCA-associated vasculitis), achieving a 5-year survival rate exceeding 90% for severe lupus patients.
• Urology: Ranked first nationally for prostate cancer diagnosis and treatment volume for 10 consecutive years, performing over 3,000 radical prostatectomies annually. Leads globally in Da Vinci robot-assisted radical prostatectomy (RARP) procedures, achieving over 95% postoperative urinary continence preservation. Pioneered “multiparametric MRI combined with targeted biopsy” technology, achieving 92% accuracy in early prostate cancer diagnosis.
• Reproductive Medicine: One of China's earliest institutions to implement assisted reproductive technologies, with in vitro fertilization (IVF) clinical pregnancy rates consistently above 55% (exceeding the national average). Specialized expertise includes fertility preservation for advanced maternal age, immunotherapy for recurrent miscarriage, and preimplantation genetic testing (PGT) for hereditary disorders.
• Critical Care Medicine: The Intensive Care Unit (ICU) is equipped with advanced technologies, including ECMO (Extracorporeal Membrane Oxygenation), High-Frequency Oscillatory Ventilation (HFOV), and Continuous Renal Replacement Therapy (CRRT). The success rate for treating critical conditions such as severe trauma, sepsis, and Acute Respiratory Distress Syndrome (ARDS) reaches 89%.
• Critical Care Treatment: The Intensive Care Unit (ICU) utilizes advanced technologies including ECMO (Extracorporeal Membrane Oxygenation), HFOV (High-Frequency Oscillatory Ventilation), and CRRT (Continuous Renal Replacement Therapy). The success rate for treating critical conditions like severe trauma, sepsis, and Acute Respiratory Distress Syndrome (ARDS) reaches 89%.
III. Hospital's Leading Specialties: The “Golden Brand” of National Key Disciplines
Renji Hospital boasts 1 National Clinical Medical Research Center (Critical Care Medicine), 7 National Key Disciplines, and 25 National Key Clinical Specialties. The following represent its core strengths:
• Gastroenterology: Ranked first in the “Fudan China Hospital Specialty Rankings” for 18 consecutive years. Specializes in early screening of gastrointestinal tumors, diagnosis and treatment of complex liver diseases (e.g., autoimmune liver disease), and pancreatic disorders (e.g., severe acute pancreatitis). Leads nationally in endoscopic minimally invasive procedures and success rates.
• Rheumatology and Immunology: As the “birthplace of rheumatology in China,” it maintains international authority in treating autoimmune diseases like systemic lupus erythematosus, rheumatoid arthritis, and ankylosing spondylitis, leading multiple international multicenter clinical trials.
• Urology: Specializing in prostate diseases, andrology, and urological tumors, the department's comprehensive prostate cancer management system (screening-diagnosis-treatment-follow-up) serves as a national benchmark. Its robotic-assisted surgery volume ranks among the world's highest.
• Obstetrics and Gynecology (Reproductive Medicine): Maintains the highest clinical pregnancy rate in East China for assisted reproductive technologies (IVF/ICSI) for five consecutive years, with extensive expertise in treating complex cases, including advanced maternal age and recurrent implantation failure.
• Hepatobiliary Surgery: Demonstrates mature expertise in early liver cancer diagnosis (e.g., liquid biopsy), complex hepatectomy (e.g., hilar cholangiocarcinoma resection), and liver transplantation (annual volume exceeding 200 cases). Achieves a 5-year postoperative survival rate of 55% for liver cancer—a level recognized as internationally advanced.
• Cardiovascular Medicine: Specializes in interventional coronary artery disease treatment (annual PCI volume exceeding 8,000 cases), radiofrequency ablation for arrhythmias (95% success rate for atrial fibrillation ablation), and structural heart disease (e.g., transcatheter aortic valve implantation, TAVI).
IV. Hospital Departments: Comprehensive Lifecycle Coverage, Building a “One-Stop” Health Management System
Renji Hospital maintains a comprehensive disciplinary system covering the entire lifecycle from prevention and diagnosis to rehabilitation:
• Internal Medicine System: Gastroenterology (national benchmark), Rheumatology and Immunology (international authority), Cardiology (leading interventional therapies), Pulmonology (lung cancer targeted therapy, pulmonary fibrosis), Nephrology (blood purification, uremia management), Endocrinology (comprehensive diabetes management, thyroid nodule ablation), etc.;
• Surgical System: Urology (Precision Prostate Cancer Diagnosis & Treatment), Hepatobiliary Surgery (Complex Liver Cancer Procedures), Gastrointestinal Surgery (Minimally Invasive Gastrointestinal Oncology), Hepatopancreatic Surgery (Leading ERCP Techniques), Breast Surgery (Breast-Conserving Breast Cancer Surgery), Orthopedics (Joint Replacement, Minimally Invasive Spine Surgery), etc.;
• Specialty and Emergency Services: Obstetrics and Gynecology (Assisted Reproductive Technology, High-Risk Pregnancies), Pediatrics (Pediatric Asthma, Congenital Heart Disease), Ophthalmology (Phacoemulsification for Cataracts, Myopia Correction), Otolaryngology (multilevel snoring surgery, ear microsurgery), Dermatology (psoriasis biologic therapy, comprehensive hair loss management), Rehabilitation Medicine (neurological rehabilitation, postoperative functional restoration), etc.;
• Medical Technology Support: Radiology (3.0T MRI, Dual-Source CT, PET-CT Precision Diagnostics), Pathology (Molecular Pathology Testing), Laboratory Medicine (High-Throughput Gene Sequencing), Nuclear Medicine (SPECT/CT, PET/MR Imaging), Ultrasound Medicine (Contrast-Enhanced Ultrasound, Interventional Ultrasound), etc., providing comprehensive “one-stop” technical support for clinical practice.
V. Medical Equipment: World-Class Technology Enabling Precision Diagnosis and Treatment
Renji Hospital continuously introduces globally leading medical equipment to provide hardware support for treating complex and critical conditions:
• Imaging Diagnostics: Equipped with 3.0T MRI, dual-source CT (sub-second scanning), PET-MR (fused MRI and positron emission tomography), and intraoperative MRI (real-time guidance for brain tumor surgery), boosting early tumor detection rates by 30%.
• Surgery and Treatment: The Da Vinci Surgical System (Xi) covers urology, general surgery, and obstetrics/gynecology; endoscopic diagnostic/therapeutic equipment (e.g., Olympus 290 Series gastroscope, endoscopic ultrasound) supports minimally invasive procedures; Interventional therapy equipment (DSA digital subtraction angiography machines) is used for cardiovascular, cerebrovascular, and oncological interventions.
• Critical Care and Emergency: ECMO (extracorporeal membrane oxygenation), high-frequency oscillatory ventilators, and continuous renal replacement therapy (CRRT) machines provide life support for patients with severe pneumonia and multiple organ failure.
• Laboratory Equipment: Fully automated gene sequencers (Illumina NovaSeq), flow cytometers (BD FACSymphony), mass spectrometers (SCIEX QTRAP), and more, supporting precision medicine research and clinical diagnostics.
VI. International Patient Services: Professional, Convenient, and Compassionate Global Healthcare
As a “Shanghai Designated Unit for Foreign Medical Services” and “China International Medical Tourism Pilot Institution,” Renji Hospital offers comprehensive convenience services for international patients:
• Multilingual Support: Professional interpreters fluent in English, Japanese, Korean, Arabic, etc., are available in outpatient and inpatient departments. Key departments such as Gastroenterology, Urology, and Rheumatology/Immunology feature physicians capable of routine English communication. A 24-hour multilingual hotline is provided (+86-21-68383199 ext. International Department).
• International Medical Department (VIP Services): Dedicated private rooms (single/double occupancy with en-suite bathrooms, TV, Wi-Fi), bilingual nursing stations, customized dietary options (halal, vegetarian, etc.). Priority outpatient appointments (“green channel” for specialist consultations within 48 hours), full hospitalization assistance (including medical record translation and test scheduling).
• Visa and Insurance Assistance: Visa extension consultation for foreign patients requiring long-term treatment (coordinated with Shanghai Exit-Entry Administration Bureau); liaison with international health insurers (e.g., MSH, Cigna, BUPA) for direct billing settlement (covering outpatient, inpatient, diagnostic, and pharmaceutical expenses).
• Cultural Adaptation Services: Religious activity rooms (Christian, Buddhist, Islamic); multilingual wayfinding signage (Chinese, English, Japanese, Korean); regular “International Patient Health Lectures” (English/Japanese) covering digestive health, prostate cancer screening, and common disease prevention.
VII. Global Patient Recognition: “Technical Excellence, Thoughtful Service”
• American Patient Robert (Post-Prostate Cancer Surgery): “After being diagnosed with prostate cancer in the U.S., my local doctor recommended watchful waiting. At Renji Hospital, the urology team used multiparametric MRI and targeted biopsy to clarify my condition, then performed radical surgery with the Da Vinci robot. Now, three months post-op, my PSA levels are normal, and urinary control has recovered well! The doctors explained every treatment step in detail in English, which gave me great peace of mind.”
• Japanese Patient Yuki (Inflammatory Bowel Disease Treatment): “I've lived with Crohn's disease for 10 years, with limited results from Japanese treatments. Renji Hospital's gastroenterology specialists used endoscopic evaluation and biologic therapy. Within three months, my abdominal pain and diarrhea significantly improved. Nurses patiently guided my medication regimen in English and recommended Shanghai's specialty cuisine, helping me maintain good health throughout treatment.”
• French patient Sophie (Assisted Reproductive Technology): “My husband and I struggled with infertility due to fallopian tube issues for years, and two IVF attempts in France failed. Renji Hospital's Reproductive Medicine team created a personalized plan for us, using third-generation IVF technology (PGT) to screen for healthy embryos. I'm now 12 weeks pregnant! The doctors and nurses answered all our questions in English, making the entire process incredibly warm and supportive.”
VIII. Contact Information, Address, and Transportation Routes
• East Campus: 160 Pujian Road, Pudong New Area, Shanghai (near Dongfang Hospital)
Tel: 021-58752345 (Main Switchboard); International Medical Department: 021-58752345 ext. 6000
• West Campus: 145 Shandong Middle Road, Huangpu District, Shanghai (near East Nanjing Road)
Tel: 021-63260930 (Main Switchboard)
• South Campus: 2000 Jiangyue Road, Minhang District, Shanghai (near Puxing Highway)
Tel: 021-54601990 (Main Switchboard)
• North Campus: 85 Wujin Road, Hongkou District, Shanghai (near Sichuan North Road)
Tel: 021-65401990 (Main Switchboard)
Transportation Routes:
• East Campus (Pudong New Area):
• Subway: Exit 3 from Line 2 “Shanghai Science and Technology Museum Station,” approximately 10-minute walk; Exit 1 from Line 18 “Pujian Road Station,” approximately 5-minute walk.
• Bus: Take Bus 970, 984, or Tunnel Line 9 to “Renji Hospital East Campus Station.”
• Driving: The hospital has an underground parking garage (entrance at 150 Pujian Road). Parking is limited on weekdays; public transportation is recommended.
• West Campus (Huangpu District):
• Subway: Exit 19 at People's Square Station (Line 1), then walk about 10 minutes; Exit 4 at Nanjing East Road Station (Line 2), then walk about 5 minutes.
• Bus: Take routes 14, 17, 20, 37, etc., and get off at “Shandong Middle Road/Beijing East Road Station.”
• By Car: The hospital has a surface parking lot (entrance at 135 Shandong Middle Road). Parking is limited; public transportation is recommended.
• South Campus (Minhang District):
• Subway: Exit 2 at Jiangyue Road Station (Line 8), then walk for about 5 minutes.
• Bus: Take Pujiang 15 or Minhang 38 bus to Renji Hospital South Campus Station.
• Driving: The hospital has an underground parking garage (entrance at 1999 Jiangyue Road) with ample parking.
From its origins as a Western medicine clinic in 1844 to its current status as a “Double First-Class” medical center, Renji Hospital remains steadfast in its mission of “healing the world with compassionate medicine.” Leveraging a century of accumulated expertise, talent, and equipment, it delivers “Chinese solutions” to patients worldwide. Whether performing precision minimally invasive digestive endoscopy or robotic prostate cancer surgery, whether establishing international guidelines for rheumatic and immune diseases or achieving breakthroughs in complex assisted reproductive cases, Renji Hospital is writing a new chapter in Chinese medicine's global advancement with an open and collaborative approach.
Document dated 2025-09-12 13:45 Modify